|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
The Use of
CD44
Variant 9 and Ki-67 Combination Can Predicts Prognosis Better Than Their Single Use in Early Gastric Cancer
Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, Jeong-Hee Lee, Sang-Ho Jeong, Young-Joon Lee, Soon Chan Hong, Woo Song Ha
Cancer Res Treat.
2019;51(4):1411-1419. Published online February 25, 2019 DOI:
https://doi.org/10.4143/crt.2018.663
Web of Science 12
Crossref 10
CD44
Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer
Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, Rock Bum Kim, Jeong-Hee Lee, Sang-Ho Jeong, Young-Joon Lee, Soon Chan Hong, Woo Song Ha
Cancer Res Treat.
2016;48(1):142-152. Published online March 17, 2015 DOI:
https://doi.org/10.4143/crt.2014.227
Web of Science 37
Crossref 33
Osteopontin,
CD44
, and NFκB Expression in Gastric Adenocarcinoma
Jung Yeon Kim, Byung-Noe Bae, Kyoung Soo Kim, Eunah Shin, Kyeongmee Park
Cancer Res Treat.
2009;41(1):29-35. Published online March 31, 2009 DOI:
https://doi.org/10.4143/crt.2009.41.1.29
Crossref 17
The Serum Assay of Soluble
CD44
Standard,
CD44
Variant 5, and
CD44
Variant 6 in Patients with Gastric Cancer
Chang Hak Yoo, Sung Hoon Noh
Cancer Res Treat.
2003;35(1):3-8. Published online February 28, 2003 DOI:
https://doi.org/10.4143/crt.2003.35.1.3
Crossref 4
Immunohistochemical Study for
CD44
v6 in Hepatocellular Carcinoma and Cholangiocarcinoma
Ki Jung Yun, Kwon Ha Yoon, Weon Cheol Han
Cancer Res Treat.
2002;34(3):170-174. Published online June 30, 2002 DOI:
https://doi.org/10.4143/crt.2002.34.3.170
Crossref 4
Expression of
CD44
Standard, Variant 6 and Relationship to the Lymph Node Metastasis in Gastric Adenocarcinoma
Joo Ho Lee, Hang Jong Yu, Byung Jo Suh, Mee Ju, Hae Kyung Lee, Jin Pok Kim
J Korean Cancer Assoc.
2000;32(4):665-673.
The Clinical Value of
CD44
in Gastric Cancer
Kyung Ho Ryu, Hyung Chul Kim, Moo Jun Baek, Ok Pyung Song, Chang Jin Kim
J Korean Cancer Assoc.
1999;31(5):921-930.
The Expression of c-erbB-2 and
CD44
Gene in Breast Cancer
Jun Heyoung Heo, Yong Gui Kim, Sung Hyuk Kim, Jai Hak Lee
J Korean Cancer Assoc.
1998;30(6):1119-1130.
Prognostic Signicance of the
CD44
and Matrix Metalloproteinase 3 ( Stromelysin 3 ) Expression in Breast Cancer
Hye Rim Park, Jin Hee Sohn, Young Euy Park
J Korean Cancer Assoc.
1995;27(4):593-602.
Expression of
CD44
Splice Variant mRNA in Bladder Cancers and its Diagnostic Application
Min Ho Suh, Won Ki Baek, Jong Wook Park, Chun Il Kim, Min Ho Suh, Byung Kil Choe
J Korean Cancer Assoc.
1995;27(3):451-459.
1
Journal Impact Factor 4.6
> Browse Articles > Search
